2023-04-012024-03-312024-03-31false13261714ORAL HEALTHCARE HOLDINGS LTD2024-09-27iso4217:GBPxbrli:pure132617142023-04-01132617142024-03-31132617142023-04-012024-03-31132617142022-04-01132617142023-03-31132617142022-04-012023-03-3113261714bus:SmallEntities2023-04-012024-03-3113261714bus:AuditExempt-NoAccountantsReport2023-04-012024-03-3113261714bus:FullAccounts2023-04-012024-03-3113261714bus:PrivateLimitedCompanyLtd2023-04-012024-03-3113261714core:WithinOneYear2024-03-3113261714core:AfterOneYear2024-03-3113261714core:WithinOneYear2023-03-3113261714core:AfterOneYear2023-03-3113261714core:ShareCapital2024-03-3113261714core:SharePremium2024-03-3113261714core:RevaluationReserve2024-03-3113261714core:OtherReservesSubtotal2024-03-3113261714core:RetainedEarningsAccumulatedLosses2024-03-3113261714core:ShareCapital2023-03-3113261714core:SharePremium2023-03-3113261714core:RevaluationReserve2023-03-3113261714core:OtherReservesSubtotal2023-03-3113261714core:RetainedEarningsAccumulatedLosses2023-03-3113261714core:LandBuildings2024-03-3113261714core:PlantMachinery2024-03-3113261714core:Vehicles2024-03-3113261714core:FurnitureFittings2024-03-3113261714core:OfficeEquipment2024-03-3113261714core:NetGoodwill2024-03-3113261714core:IntangibleAssetsOtherThanGoodwill2024-03-3113261714core:ListedExchangeTraded2024-03-3113261714core:UnlistedNon-exchangeTraded2024-03-3113261714core:LandBuildings2023-03-3113261714core:PlantMachinery2023-03-3113261714core:Vehicles2023-03-3113261714core:FurnitureFittings2023-03-3113261714core:OfficeEquipment2023-03-3113261714core:NetGoodwill2023-03-3113261714core:IntangibleAssetsOtherThanGoodwill2023-03-3113261714core:ListedExchangeTraded2023-03-3113261714core:UnlistedNon-exchangeTraded2023-03-3113261714core:LandBuildings2023-04-012024-03-3113261714core:PlantMachinery2023-04-012024-03-3113261714core:Vehicles2023-04-012024-03-3113261714core:FurnitureFittings2023-04-012024-03-3113261714core:OfficeEquipment2023-04-012024-03-3113261714core:NetGoodwill2023-04-012024-03-3113261714core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3113261714core:ListedExchangeTraded2023-04-012024-03-3113261714core:UnlistedNon-exchangeTraded2023-04-012024-03-3113261714core:MoreThanFiveYears2023-04-012024-03-3113261714core:Non-currentFinancialInstruments2024-03-3113261714core:Non-currentFinancialInstruments2023-03-3113261714dpl:CostSales2023-04-012024-03-3113261714dpl:DistributionCosts2023-04-012024-03-3113261714core:LandBuildings2023-04-012024-03-3113261714core:PlantMachinery2023-04-012024-03-3113261714core:Vehicles2023-04-012024-03-3113261714core:FurnitureFittings2023-04-012024-03-3113261714core:OfficeEquipment2023-04-012024-03-3113261714dpl:AdministrativeExpenses2023-04-012024-03-3113261714core:NetGoodwill2023-04-012024-03-3113261714core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3113261714dpl:GroupUndertakings2023-04-012024-03-3113261714dpl:ParticipatingInterests2023-04-012024-03-3113261714dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3113261714core:ListedExchangeTraded2023-04-012024-03-3113261714dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3113261714core:UnlistedNon-exchangeTraded2023-04-012024-03-3113261714dpl:CostSales2022-04-012023-03-3113261714dpl:DistributionCosts2022-04-012023-03-3113261714core:LandBuildings2022-04-012023-03-3113261714core:PlantMachinery2022-04-012023-03-3113261714core:Vehicles2022-04-012023-03-3113261714core:FurnitureFittings2022-04-012023-03-3113261714core:OfficeEquipment2022-04-012023-03-3113261714dpl:AdministrativeExpenses2022-04-012023-03-3113261714core:NetGoodwill2022-04-012023-03-3113261714core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3113261714dpl:GroupUndertakings2022-04-012023-03-3113261714dpl:ParticipatingInterests2022-04-012023-03-3113261714dpl:GroupUndertakingscore:ListedExchangeTraded2022-04-012023-03-3113261714core:ListedExchangeTraded2022-04-012023-03-3113261714dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-04-012023-03-3113261714core:UnlistedNon-exchangeTraded2022-04-012023-03-3113261714core:NetGoodwill2024-03-3113261714core:IntangibleAssetsOtherThanGoodwill2024-03-3113261714core:LandBuildings2024-03-3113261714core:PlantMachinery2024-03-3113261714core:Vehicles2024-03-3113261714core:FurnitureFittings2024-03-3113261714core:OfficeEquipment2024-03-3113261714core:AfterOneYear2024-03-3113261714core:WithinOneYear2024-03-3113261714core:ListedExchangeTraded2024-03-3113261714core:UnlistedNon-exchangeTraded2024-03-3113261714core:ShareCapital2024-03-3113261714core:SharePremium2024-03-3113261714core:RevaluationReserve2024-03-3113261714core:OtherReservesSubtotal2024-03-3113261714core:RetainedEarningsAccumulatedLosses2024-03-3113261714core:NetGoodwill2023-03-3113261714core:IntangibleAssetsOtherThanGoodwill2023-03-3113261714core:LandBuildings2023-03-3113261714core:PlantMachinery2023-03-3113261714core:Vehicles2023-03-3113261714core:FurnitureFittings2023-03-3113261714core:OfficeEquipment2023-03-3113261714core:AfterOneYear2023-03-3113261714core:WithinOneYear2023-03-3113261714core:ListedExchangeTraded2023-03-3113261714core:UnlistedNon-exchangeTraded2023-03-3113261714core:ShareCapital2023-03-3113261714core:SharePremium2023-03-3113261714core:RevaluationReserve2023-03-3113261714core:OtherReservesSubtotal2023-03-3113261714core:RetainedEarningsAccumulatedLosses2023-03-3113261714core:NetGoodwill2022-04-0113261714core:IntangibleAssetsOtherThanGoodwill2022-04-0113261714core:LandBuildings2022-04-0113261714core:PlantMachinery2022-04-0113261714core:Vehicles2022-04-0113261714core:FurnitureFittings2022-04-0113261714core:OfficeEquipment2022-04-0113261714core:AfterOneYear2022-04-0113261714core:WithinOneYear2022-04-0113261714core:ListedExchangeTraded2022-04-0113261714core:UnlistedNon-exchangeTraded2022-04-0113261714core:ShareCapital2022-04-0113261714core:SharePremium2022-04-0113261714core:RevaluationReserve2022-04-0113261714core:OtherReservesSubtotal2022-04-0113261714core:RetainedEarningsAccumulatedLosses2022-04-0113261714core:AfterOneYear2023-04-012024-03-3113261714core:WithinOneYear2023-04-012024-03-3113261714core:Non-currentFinancialInstrumentscore:CostValuation2023-04-012024-03-3113261714core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-04-012024-03-3113261714core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-04-012024-03-3113261714core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-04-012024-03-3113261714core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-04-012024-03-3113261714core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-04-012024-03-3113261714core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3113261714core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3113261714core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3113261714core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3113261714core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3113261714core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3113261714core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3113261714core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3113261714core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3113261714core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3113261714core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3113261714core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3113261714core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3113261714core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3113261714core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3113261714core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3113261714core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3113261714core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3113261714core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3113261714core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3113261714core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3113261714bus:Director12023-04-012024-03-31

ORAL HEALTHCARE HOLDINGS LTD

Registered Number
13261714
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2024

ORAL HEALTHCARE HOLDINGS LTD
Company Information
for the year from 1 April 2023 to 31 March 2024

Director

PATEL, Sundeep

Registered Address

281 Brownhill Road
Catford
London
SE6 1AE

Registered Number

13261714 (England and Wales)
ORAL HEALTHCARE HOLDINGS LTD
Balance Sheet as at
31 March 2024

Notes

2024

2023

£

£

£

£

Current assets
Debtors3,416,086824
Cash at bank and on hand23,40618,702
39,49219,526
Creditors amounts falling due within one year5(47,886)(20,686)
Net current assets (liabilities)(8,394)(1,160)
Total assets less current liabilities(8,394)(1,160)
Net assets(8,394)(1,160)
Capital and reserves
Called up share capital100100
Profit and loss account(8,494)(1,260)
Shareholders' funds(8,394)(1,160)
The financial statements were approved and authorised for issue by the Director on 27 September 2024, and are signed on its behalf by:
PATEL, Sundeep
Director
Registered Company No. 13261714
ORAL HEALTHCARE HOLDINGS LTD
Notes to the Financial Statements
for the year ended 31 March 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
2.Average number of employees

20242023
Average number of employees during the year00
3.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables14,980-
Other debtors1,106824
Total16,086824
4.Debtors: amounts due after one year
5.Creditors: amounts due within one year

2024

2023

££
Bank borrowings and overdrafts47,22620,026
Accrued liabilities and deferred income660660
Total47,88620,686